by Elena Iemma | May 16, 2023 | Featured, News
EpiVax is celebrating 25 years of innovative immunoinformatics tool development. The company’s mission is to improve the safety and efficacy of vaccines and protein therapeutics, while working to improve human health everywhere. 1998 EpiVax Founded by Dr. Annie De...
by Riley Nolan | Jun 10, 2022 | Featured, News
PROVIDENCE, RI, June 10, 2022 /PRNewswire/ — EpiVax, Inc. (“EpiVax”) announces that it has developed VennVax, a smallpox vaccine candidate that is predicted to be highly effective against monkeypox. The development of this vaccine was funded by the National...
by Riley Nolan | May 26, 2022 | Featured, Thinking Out Loud -Blog
Monkeypox, Avian Influenza and Q Fever, Oh My! Before getting to other news, we share your sorrow and horror over the lives lost in Texas this week and agree that common sense gun legislation is long overdue in the USA. EpiVax team members are appalled and saddened...
by Annie De Groot | Mar 4, 2020 | Featured, News
PROVIDENCE, R.I., Mar. 4, 2020 – EpiVax Inc., a Rhode Island company, announces a collaboration to develop a novel coronavirus SARS-CoV-2 (COVID-19) vaccine with University of Georgia (UGA, Athens GA) vaccine expert Ted Ross (Director, Center for Vaccines and...
by Annie De Groot | Feb 28, 2020 | Events
The 2020 meeting for the National Foundation for Infectious Diseases is taking place at the The Omni Shoreham Hotel in Washington DC, from March 23-25. During the meeting, EpiVax will be represented by Dr. Lenny Moise, director of Vaccines, Dr. Lauren Meyers, of the...